Literature DB >> 7586799

In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.

H Xie1, T Turner, M H Wang, R K Singh, G P Siegal, A Wells.   

Abstract

Prostate carcinomas often present an autocrine stimulatory loop in which the transformed cells both express the EGF receptor (EGFR) and produce activating ligands (TGF alpha and EGF forms). Up-regulated EGFR signalling has been correlated with tumor progression in other human neoplasia; however, the cell behaviour which is promoted remains undefined. To determine whether an EGFR-induced response contributes to cell invasiveness, we transduced DU-145 human prostate carcinoma cells with either a full-length (WT) or a mitogenically-active but motility-deficient truncated (c'973) EGFR. The DU-145 Parental and two transgene sublines all produced EGFR and TGF alpha, but the transduced WT and c'973 EGFR underwent autocrine downregulation to a lesser degree, with more receptor remaining intact. DU-145 cells transduced with WT EGFR transmigrated a human amniotic basement membrane matrix (Amgel) to a greater extent than did Parental DU-145 cells (175 +/- 22%). Cells expressing the c'973 EGFR invaded through the Amgel only to about two thirds the extent of the Parental cells (62 +/- 23%). A monoclonal antibody which prevents ligand-induced activation of EGFR decreased the invasiveness of WT-expressing cells by half and Parental cells by a fifth, but had little effect on the invasiveness of c'973-expressing cells; with the result that in the presence of antibody, all three cell lines transmigrated the Amgel to the same extent. The different levels of invasiveness between the three sublines were independent of cell proliferation. These findings demonstrated that EGFR-mediated signals increase tumor cell invasiveness and suggested that domains in the carboxy-terminus are required to signal invasiveness. As an initial investigation into the mechanisms underlying the EGFR-mediated enhanced invasiveness, we determined whether these cells presented different collagenolytic activity, as the major constituents of Amgel are collagen types I and IV. All three sublines secreted easily detectable levels of gelatin-directed proteases and TIMP-1, with WT cells secreting equivalent or lower levels of proteases. The proteolytic balance in these cells did not correlate with invasiveness. These data suggest that the TGF alpha-EGFR autocrine loop promotes invasiveness and that this is accomplished by signalling cell properties other than differential secretion of collagenolytic activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586799     DOI: 10.1007/BF00118180

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  62 in total

1.  Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.

Authors:  W S Chen; C S Lazar; K A Lund; J B Welsh; C P Chang; G M Walton; C J Der; H S Wiley; G N Gill; M G Rosenfeld
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

2.  Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines.

Authors:  G L Morris; J G Dodd
Journal:  J Urol       Date:  1990-06       Impact factor: 7.450

Review 3.  Analyzing the metastatic phenotype.

Authors:  J E Price
Journal:  J Cell Biochem       Date:  1994-09       Impact factor: 4.429

4.  Epidermal growth factor stimulates the synthesis of cell-attachment proteins in the human breast cancer cell line PMC42.

Authors:  H J Thorne; D G Jose; H Y Zhang; P J Dempsey; R H Whitehead
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

Review 5.  Amplified genes in human gliomas.

Authors:  V P Collins
Journal:  Semin Cancer Biol       Date:  1993-02       Impact factor: 15.707

6.  Prevention of metastasis by inhibition of the urokinase receptor.

Authors:  C W Crowley; R L Cohen; B K Lucas; G Liu; M A Shuman; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

Review 8.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

Authors:  J G Klijn; P M Berns; P I Schmitz; J A Foekens
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

9.  Kinetics of binding, endocytosis, and recycling of EGF receptor mutants.

Authors:  S Felder; J LaVin; A Ullrich; J Schlessinger
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

10.  A negative feedback loop attenuates EGF-induced morphological changes.

Authors:  J B Welsh; G N Gill; M G Rosenfeld; A Wells
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more
  23 in total

1.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis.

Authors:  Muhammad H Zaman; Linda M Trapani; Alisha L Sieminski; Alisha Siemeski; Drew Mackellar; Haiyan Gong; Roger D Kamm; Alan Wells; Douglas A Lauffenburger; Paul Matsudaira
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

3.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Authors:  T Turner; P Chen; L J Goodly; A Wells
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

4.  Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.

Authors:  Jacqueline Jones; Honghe Wang; Jianjun Zhou; Shana Hardy; Timothy Turner; David Austin; Qinghua He; Alan Wells; William E Grizzle; Clayton Yates
Journal:  Am J Pathol       Date:  2012-09-10       Impact factor: 4.307

5.  Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.

Authors:  Y Ward; W Wang; E Woodhouse; I Linnoila; L Liotta; K Kelly
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.

Authors:  M Zhang; R K Singh; M H Wang; A Wells; G P Siegal
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

7.  Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines.

Authors:  Ludmila Sviridonov; Masha Dobkin-Bekman; Boris Shterntal; Fiorenza Przedecki; Linor Formishell; Shani Kravchook; Liat Rahamim-Ben Navi; Tali Hana Bar-Lev; Marcelo G Kazanietz; Zhong Yao; Rony Seger; Zvi Naor
Journal:  Mol Cell Endocrinol       Date:  2013-02-01       Impact factor: 4.102

8.  Role of proprotein convertases in prostate cancer progression.

Authors:  Frédéric Couture; François D'Anjou; Roxane Desjardins; François Boudreau; Robert Day
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

Review 9.  Redox control of vascular smooth muscle migration.

Authors:  Alejandra San Martín; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

10.  Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line.

Authors:  R Banerjee; Z Rachid; Q Qiu; J P McNamee; A M Tari; B J Jean-Claude
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.